fbpx

Health Care

NJ Health Insurance Fund partners with R-Health to improve patient-doctor access and health outcomes

Bringing back the power of the close doctor-patient relationship and improving access to health care is the focus of a new collaborative partnership between the New Jersey Health Insurance Fund (hi) and R-Health which is based in Elkins Park, Pa. The “hi” fund will be piloting R-Health’s model of enhanced primary care with members of ...

Read More »

Rowan breaks ground on two-building expansion project

Rowan College of South Jersey broke ground Sept. 13 on a two-building academic and office complex. The first segment of the project will be an Economic Development Center — a one-story, 15,633 square foot building that will house the New Jersey Department of Labor and Workforce Development, the Gloucester County Chamber of Commerce and the ...

Read More »

Soligenix appoints biopharma veteran to executive post

Soligenix, Inc. a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases announced that it has appointed Daniel P. Ring as Vice President of Business Development and Strategic Planning, effective immediately. Ring has over 22 years of business development and commercial experience in the biopharmaceutical industry. In this new role, he ...

Read More »

CarePlus awarded $4M to expand employment services

Paramus-based Care Plus NJ Inc. said Sept. 16 that it has been awarded $4 million dollars over the next five years in grant funding to expand its Supported Employment Services for individuals with persistent and serious mental illness by the federal Substance Abuse and Mental Health Services Administration (SAMHSA). The funding has been allocated through the ‘Transforming ...

Read More »

Bayer names Foster new head of public affairs and sustainability for Consumer Health Division

Whippany-based Bayer announced on Monday that it has named Daniella Foster as the new Head of Public Affairs and Sustainability for the Consumer Health Division, effective today. In her new role, Foster will be responsible for the development and execution of the Division’s global Public Affairs and Sustainability strategies. She will report to Heiko Schipper, ...

Read More »

Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies

Bridgewater–based Sanofi and Abbott have announced that they are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their condition. The two companies will take an innovative approach to connected care by developing tools that combine the revolutionary FreeStyle Libre technology with insulin dosing ...

Read More »

A new ICU model improves overall quality of pharmacy services delivered to patients (access required)

Rutgers University and RWJBarnabas Health System have developed a new model for ICU pharmacists that helps them address a common dilemma and improve care for critically ill patients. ICUs usually include a team of general practice pharmacists, augmented by one who specializes in critical care. In most cases, only the specialist can respond to complex, ...

Read More »

Quest Diagnostics and hc1 collaborate to optimize enterprise-wide laboratory testing for Health Systems

Secaucus-based Quest Diagnostics unveiled Quest Lab Stewardship powered by hc1, an innovative new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization. Quest Lab Stewardship is the result of a strategic collaboration between Quest and hc1 focused on improving costs and clinical impact of ...

Read More »

Castle Creek Pharmaceutical Holdings announces agreement to acquire Fibrocell

Parsippany-based Castle Creek Pharmaceutical Holdings, Inc. announced that it reached an agreement to acquire Exton, PA-based Fibrocell Science, Inc., a cell and gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases. With the resources of CCP Holdings’ subsidiary, Castle Creek Pharmaceuticals Fibrocell’s gene therapy platform can be advanced into ...

Read More »